
When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully

When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully

Published: February 27th 2013 | Updated: